Illumina, Inc. today announced that it has completed its acquisition of SomaLogic, a leader in data-driven proteomics ...
Veteran genomics leader joins Illumina to advance global medical strategyIllumina chief commercial officer to depart for role as a life science tools ...
AI across the pharmaceutical ecosystem. The Illumina Billion Cell Atlas is the first tranche of its program to build a 5 billion cell atlas over three years, and will be the most comprehensive map of ...
Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.
Sun River Health has been selected as a 2025 Quality Award winner by the New York State Department of Health's Center for ...
Our Bureau, Bengaluru Monday, February 2, 2026, 11:20 Hrs [IST] ...
Researchers are now exploring how to best extract and use saliva-derived DNA for long-read sequencing applications. Download ...
Scientists from UC San Diego’s Scripps Institution of Oceanography and the Scripps Polar Center are at the bottom of the ...
Summary: Edge AI is shifting AI inference away from expensive cloud data centers and onto local devices. As this transition ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Illumina became a genomics juggernaut by developing machines that could read large ...
Nearly a year after leaving his position as longtime director of the National Human Genome Research Institute (NHGRI), Eric Green, M.D., Ph.D., will now step into the commercial life sciences world as ...
Integrated software, AI-driven analytics, and frictionless workflows enable customers to harness the full power of biological insights SAN DIEGO, Jan. 6, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results